AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 86292 — intervention group
Group type: COMPARATOR
Intervention: Mismatched instruction (Group IIb)
Number of subjects: 211
Study 86292 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched instruction (Group IIIa)
Number of subjects: 211
Study 86292 — intervention group
Group type: COMPARATOR
Intervention: High structure in symbolic mode of instruction (Group IIIb)
Number of subjects: 211
Study 86292 — intervention group
Group type: EXPERIMENTAL
Intervention: High structure in symbolic mode of instruction
Number of subjects: 211
Study 86292 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional level of structure
Number of subjects: 211
Study 30033781 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic fluid (AF) Na and K levels
Number of subjects: 0
Study 30033781 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic fluid (AF) Na levels
Number of subjects: 0
Study 30033781 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic fluid (AF) pH
Number of subjects: 0
Study 28105513 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo terpene lactones meglumine injection (GMI)
Number of subjects: 15
Study 28105513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 26421861 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Prevention (CBP) program consisting of 8 weekly 90-minute group sessions followed by 6 monthly continuation sessions.
Number of subjects: 316
Study 26421861 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Prevention (CBP) program
Number of subjects: 316
Study 26421861 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 316
Study 23343061 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginesatide administered once monthly
Number of subjects: 1608
Study 23343061 — intervention group
Group type: COMPARATOR
Intervention: Epoetin administered one to three times per week
Number of subjects: 1608
Study 23343061 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginesatide
Number of subjects: 1608
Study 23343061 — intervention group
Group type: COMPARATOR
Intervention: Epoetin
Number of subjects: 1608
Study 16463044 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese women (OB) during submaximal cycling
Number of subjects: 18
Study 16463044 — intervention group
Group type: COMPARATOR
Intervention: Comparison of actual VO2 measured with predicted VO2
Number of subjects: 18
Study 15285777 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (200 mg as Sinemet)
Number of subjects: 11
Study 15285777 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa treatment
Number of subjects: 11
Study 11103753 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion for 6 hours
Number of subjects: 9
Study 11103753 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion with valsartan pretreatment
Number of subjects: 9
Study 11103753 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion
Number of subjects: 9
Study 8781824 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 81
Study 8781824 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise training
Number of subjects: 81
Study 8781824 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81
Study 1449046 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox (250 mg x 3) for three months
Number of subjects: 12
Study 1449046 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox (after three months treatment)
Number of subjects: 12
Study 1449046 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox (before treatment)
Number of subjects: 12
Study 1449046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2936352 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 0
Study 2936352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30976922 — intervention group
Group type: EXPERIMENTAL
Intervention: UEScope
Number of subjects: 93
Study 30976922 — intervention group
Group type: COMPARATOR
Intervention: Miller
Number of subjects: 93
Study 29275345 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 320
Study 29275345 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal cannula (HFNC) oxygen therapy
Number of subjects: 320
Study 25935098 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyquaternium-1-preserved travoprost 0.003%
Number of subjects: 864
Study 25935098 — intervention group
Group type: COMPARATOR
Intervention: Benzalkonium chloride-preserved travoprost 0.004%
Number of subjects: 864
Study 23903772 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 30467
Study 21299297 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (20 or 40 min/day for 13 ± 1.6 weeks)
Number of subjects: 171
Study 21299297 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 171
Study 19826309 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise at 60-65% 1 repetition maximum (1RM)
Number of subjects: 13
Study 19826309 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise at 80-85% 1 repetition maximum (1RM)
Number of subjects: 13
Study 19826309 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise at both intensities (60-85% 1RM)
Number of subjects: 13
Study 16834838 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol ER 100 mg once daily
Number of subjects: 1020
Study 16834838 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol ER 200 mg once daily
Number of subjects: 1020
Study 16834838 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol ER 300 mg once daily
Number of subjects: 1020
Study 16834838 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol ER 400 mg once daily
Number of subjects: 1020
Study 16834838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1020
Study 12768357 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment of 100 mg regular-release (rr) and 100 mg sustained-release (sr) L-dopa/benserazide
Number of subjects: 21
Study 12768357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 12768357 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment of 100 mg regular-release (rr) and 100 mg sustained-release (sr) L-dopa/benserazide after 4 weeks
Number of subjects: 21
Study 12768357 — intervention group
Group type: COMPARATOR
Intervention: Placebo after 4 weeks
Number of subjects: 21
Study 10671905 — intervention group
Group type: COMPARATOR
Intervention: Milnacipran 12.5 mg, 25 mg, 50 mg, 100 mg (single dose)
Number of subjects: 10
Study 10671905 — intervention group
Group type: COMPARATOR
Intervention: Milnacipran 75 mg (50 mg + 25 mg) per day
Number of subjects: 10
Study 10671905 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline 50 mg (25 mg + 25 mg) per day
Number of subjects: 10
Study 10671905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 9176040 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodilatin infusion (20 ng min‐1 kg‐1)
Number of subjects: 12
Study 9176040 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodilatin infusion (40 ng min‐1 kg‐1)
Number of subjects: 12
Study 9176040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8260563 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (optimal drug dosage)
Number of subjects: 32
Study 8260563 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 32
Study 3910338 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% NaF solution rinse every fortnight
Number of subjects: 251
Study 3910338 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Fluor‐Protector) biannual applications
Number of subjects: 251
Study 3910338 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 251
Study 31327525 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical shape modelling (SSM)
Number of subjects: 153
Study 29656744 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib
Number of subjects: 207
Study 29656744 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 207
Study 26842005 — intervention group
Group type: EXPERIMENTAL
Intervention: Kindness questionnaire
Number of subjects: 307
Study 26842005 — intervention group
Group type: EXPERIMENTAL
Intervention: Values essay
Number of subjects: 307
Study 26842005 — intervention group
Group type: EXPERIMENTAL
Intervention: Attributes questionnaire
Number of subjects: 307
Study 26842005 — intervention group
Group type: COMPARATOR
Intervention: Control questionnaire
Number of subjects: 307
Study 25228778 — intervention group
Group type: EXPERIMENTAL
Intervention: PPL-EMR intervention
Number of subjects: 132
Study 25228778 — intervention group
Group type: EXPERIMENTAL
Intervention: PPL-ASSESS intervention
Number of subjects: 132
Study 25228778 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 132
Study 25228778 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall improvement
Number of subjects: 132
Study 22012149 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 65
Study 22012149 — intervention group
Group type: COMPARATOR
Intervention: Weekly Monitoring Control
Number of subjects: 65
Study 20734060 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing a composition (Robert Schumann's "Phantasiestücke" Op. 73 for clarinet and piano)
Number of subjects: 15
Study 18593278 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 44
Study 18593278 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-induced weight loss
Number of subjects: 44
Study 18593278 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study 16097222 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbst appliance
Number of subjects: 30
Study 16097222 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated Class II children)
Number of subjects: 30
Study 12523587 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple regimens containing ranitidine bismuth and metronidazole, with either oxytetracycline or spiramycine.
Number of subjects: 183
Study 10353520 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone and proguanil hydrochloride
Number of subjects: 168
Study 10353520 — intervention group
Group type: COMPARATOR
Intervention: Halofantrine
Number of subjects: 168
Study 8602663 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine group
Number of subjects: 10
Study 1685166 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound therapy
Number of subjects: 61
Study 1685166 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortwave diathermy
Number of subjects: 61
Study 1685166 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound and exercise program
Number of subjects: 61
Study 1685166 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortwave diathermy and exercise therapy
Number of subjects: 61
Study 1685166 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 61
Study 7139526 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + CT
Number of subjects: 5
Study 7139526 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Lymphoid Irradiation (TLI)
Number of subjects: 5
Study 7139526 — intervention group
Group type: COMPARATOR
Intervention: Local radiation with or without chemotherapy
Number of subjects: 5
Study 31440895 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Modic changes and considerable inflammation
Number of subjects: 119
Study 31440895 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Modic changes and mild inflammation
Number of subjects: 119
Study 31440895 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with extruded discs with Modic changes and considerable inflammation
Number of subjects: 119
Study 31440895 — intervention group
Group type: COMPARATOR
Intervention: Patients with bulging discs
Number of subjects: 119
Study 28944412 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium picosulfate/magnesium citrate (SPMC)
Number of subjects: 973
Study 28944412 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume polyethylene glycol/ascorbic acid (PEGA)
Number of subjects: 973
Study 28944412 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol (PEG)
Number of subjects: 973
Study 28944412 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-dose regimen (all solutions)
Number of subjects: 973
Study 28944412 — intervention group
Group type: COMPARATOR
Intervention: Single-dose regimen (all solutions)
Number of subjects: 973
Study 25524612 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Text intervention for sun protection (N=187)
Number of subjects: 546
Study 25524612 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Text intervention for skin self-examination (N=176)
Number of subjects: 546
Study 25524612 — intervention group
Group type: COMPARATOR
Intervention: Attention control (N=183)
Number of subjects: 546
Study 25524612 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin self-examination intervention (N=176)
Number of subjects: 546
Study 25524612 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun protection intervention (N=187)
Number of subjects: 546
Study 24315548 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutting balloon angioplasty (CBA)
Number of subjects: 71
Study 24315548 — intervention group
Group type: COMPARATOR
Intervention: High-pressure balloon angioplasty (HPBA)
Number of subjects: 71
Study 21111555 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted-dose warfarin (target INR 2 to 3)
Number of subjects: 7329
Study 21111555 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose ximelagatran 36 mg twice daily
Number of subjects: 7329
Study 19478213 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator (tPA)
Number of subjects: 1622
Study 19478213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1622
Study 17288690 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietic protein therapy
Number of subjects: 0
Study 17288690 — intervention group
Group type: COMPARATOR
Intervention: Blood transfusion
Number of subjects: 0
Study 15044883 — intervention group
Group type: EXPERIMENTAL
Intervention: Simethicone (80 mg)
Number of subjects: 36
Study 15044883 — intervention group
Group type: COMPARATOR
Intervention: No supplemental medication
Number of subjects: 36
Study 11675170 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire mailed to patients
Number of subjects: 300
Study 11675170 — intervention group
Group type: COMPARATOR
Intervention: Questionnaire given at the hospital
Number of subjects: 300
Study 11675170 — intervention group
Group type: COMPARATOR
Intervention: No reminders
Number of subjects: 300
Study 11675170 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminders sent after initial response
Number of subjects: 300
Study 9635472 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic strength of knee extension and flexion at slow speed
Number of subjects: 23
Study 9635472 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic strength of knee extension and flexion at fast speed
Number of subjects: 23
Study 7877874 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal exposure to betamethasone and indomethacin
Number of subjects: 147
Study 7877874 — intervention group
Group type: COMPARATOR
Intervention: Prenatal exposure to indomethacin
Number of subjects: 147
Study 7877874 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal GFR measurements on d 10 after birth
Number of subjects: 147
Study 3243093 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil once daily
Number of subjects: 250
Study 3243093 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor thrice daily
Number of subjects: 250
Study 30649899 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted vest (18.10 kg)
Number of subjects: 50
Study 30649899 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 50
Study 30649899 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted vest
Number of subjects: 50
Study 27173517 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-183-5p, miR-486-5p, miR-30c-2-3p, miR-133a-3p (validated using qRT-PCR)
Number of subjects: 53
Study 27173517 — intervention group
Group type: EXPERIMENTAL
Intervention: 22 GC specific key miRNAs identified (Fold-change >2, P < 0.05)
Number of subjects: 53
Study 26314881 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy with passive cycle ergometer intervention (20 min, 20 rpm, once per day, 7 days a week)
Number of subjects: 28
Study 26314881 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 28
Study 24169612 — intervention group
Group type: EXPERIMENTAL
Intervention: Bardoxolone methyl added to guideline-recommended treatment including inhibitors of the renin-angiotensin-aldosterone system
Number of subjects: 2185
Study 24169612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2185
Study 21159499 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (18 μg) after 30 days
Number of subjects: 29
Study 21159499 — intervention group
Group type: COMPARATOR
Intervention: Placebo after 30 days
Number of subjects: 29
Study 19051853 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct digital radiographic (DDR) system (RVG‐6000)
Number of subjects: 51
Study 19051853 — intervention group
Group type: COMPARATOR
Intervention: Conventional bitewing radiographs (D‐speed film)
Number of subjects: 51
Study 19051853 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of radiographs
Number of subjects: 51
Study 19051853 — intervention group
Group type: COMPARATOR
Intervention: D‐speed film
Number of subjects: 51
Study 19051853 — intervention group
Group type: EXPERIMENTAL
Intervention: RVG‐6000 sensor
Number of subjects: 51
Study 17077374 — intervention group
Group type: EXPERIMENTAL
Intervention: CIMT (n = 106; wearing a restraining mitt on the less‐affected hand while engaging in repetitive task practice and behavioral shaping with the hemiplegic hand)
Number of subjects: 222
Study 17077374 — intervention group
Group type: EXPERIMENTAL
Intervention: CIMT (n = 106)
Number of subjects: 222
Study 17077374 — intervention group
Group type: COMPARATOR
Intervention: Usual and customary care (n = 116; ranging from no treatment after concluding formal rehabilitation to pharmacologic or physiotherapeutic interventions)
Number of subjects: 222
Study 17077374 — intervention group
Group type: COMPARATOR
Intervention: Usual and customary care (n = 116)
Number of subjects: 222
Study 12798886 — intervention group
Group type: COMPARATOR
Intervention: Goserelin (3.6 mg, s.c. injection)
Number of subjects: 307
Study 12798886 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant (50 mg, 125 mg, or 250 mg, i.m. injection)
Number of subjects: 307
Study 10827391 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 29
Study 10827391 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 29
Study 8719647 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (25-50 U)
Number of subjects: 17
Study 8719647 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intramuscular saline)
Number of subjects: 17
Study 1711873 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0
Study 1711873 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone
Number of subjects: 0
Study 1711873 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose prednisolone
Number of subjects: 0
Study 1711873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1711873 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (all types)
Number of subjects: 0
Study 6130751 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy (BT)
Number of subjects: 0
Study 6130751 — intervention group
Group type: COMPARATOR
Intervention: Supportive psychotherapy (ST)
Number of subjects: 0
Study 3875451 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg pirazolac 3-times daily for 7 days
Number of subjects: 10
Study 3875451 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg diclofenac sodium 3-times daily for 7 days
Number of subjects: 10
Study 3875451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 28940213 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit reversal treatment (HR) + mometasone furoate (potent steroid)
Number of subjects: 39
Study 28940213 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate (potent steroid) alone
Number of subjects: 39
Study 27684483 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic urethral lift (PUL) procedure
Number of subjects: 53
Study 27684483 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 53
Study 24071762 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentaerithrityl tetranitrate (PETN) 80 mg b.i.d.
Number of subjects: 655
Study 24071762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 655
Study 22533659 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention targeting physician, patient, and office system factors
Number of subjects: 591
Study 22533659 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 591
Study 20064822 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins (Group 1)
Number of subjects: 372
Study 20064822 — intervention group
Group type: EXPERIMENTAL
Intervention: RAAS inhibitors (Group 2)
Number of subjects: 372
Study 20064822 — intervention group
Group type: COMPARATOR
Intervention: Control (Group 3)
Number of subjects: 372
Study 20064822 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 372
Study 20064822 — intervention group
Group type: EXPERIMENTAL
Intervention: RAAS inhibitors
Number of subjects: 372
Study 20064822 — intervention group
Group type: COMPARATOR
Intervention: Statins vs Control
Number of subjects: 372
Study 20064822 — intervention group
Group type: COMPARATOR
Intervention: RAAS inhibitors vs Control
Number of subjects: 372
Study 19018483 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 0